Drug recall · May 24, 2023
Heparin Sodium recall
Why: Subpotent: Low anti-factor IIa Potency.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Heparin Sodium, 25,000 USP units per 250mL, (100 USP units per mL) in 5% Dextrose injection, 250 ml Excel Container, B. Braun Medical Inc. Bethlehem, PA 18018, USA; API from Spain NDC: 0264-9587-20,
- Lots / codes
Lot Number: J1P154N, Exp: 31 May, 2023,
- Quantity
- 1,380
- Company
- B. Braun Medical Inc, Irvine, CA
- Distribution
- Nationwide in the USA
- Initiated
- May 9, 2023 · Voluntary: Firm initiated
- Classified
- May 16, 2023
- Reported
- May 24, 2023
- Ended
- March 14, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Heparin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.